Objective To investigate the impact of ageing on survival outcomes in Bacillus Calmette–Guérin (BCG) treated non-muscle invasive bladder cancer (NMIBC) patients and its synergy with adequate BCG treatment. Method Patients with NMIBC who received BCG treatment from 2001 to 2020 were divided into group 1 (<=70 years) and group 2 (>70 years). Overall Survival (OS), Cancer-Specifc Survival (CSS), Recurrence-Free Survival (RFS), and Progression-Free Survival (PFS) were analyzed using the Kaplan–Meier method. Multivariable Cox regression analysis was used to adjust potential confounding factors and to estimate Hazard Ratio (HR) and 95% Confdence Interval (CI). Subgroup analysis was performed according to adequate versus inadequate BCG treatment. Results Overall, 2602 NMIBC patients were included: 1051 (40.4%) and 1551 (59.6%) in groups 1 and 2, respectively. At median follow-up of 11.0 years, group 1 (<=70 years) was associated with better OS, CSS, and RFS, but not PFS as compared to group 2 (>70 years). At subgroup analysis, patients in group 1 treated with adequate BCG showed better OS, CSS, RFS, and PFS as compared with inadequate BCG treatment in group 2, while patients in group 2 receiving adequate BCG treatment had 41% less progression than those treated with inadequate BCG from the same group. Conclusions Being younger (<=70 years) was associated with better OS, CSS, and RFS, but not PFS. Older patients (>70 years) who received adequate BCG treatment had similar PFS as those younger with adequate BCG treatment.

Young age and adequate BCG are key factors for optimal BCG treatment efficacy in non-muscle-invasive bladder cancer / Liu, Kang; Nicoletti, Rossella; Zhao, Hongda; Chen, Xuan; Wu, Hongwei; Leung, Chi-Ho; D'Andrea, David; Laukhtina, Ekaterina; Soria, Francesco; Gallioli, Andrea; Wroclawski, Marcelo Langer; Castellani, Daniele; Gauhar, Vineet; Rivas, Juan Gomez; Enikeev, Dmitry; Gontero, Paolo; Shariat, Shahrokh F.; Chiu, Peter Ka-Fung; Ng, Chi-Fai; Teoh, Jeremy Yuen-Chun. - In: WORLD JOURNAL OF UROLOGY. - ISSN 1433-8726. - 42:(2024). [10.1007/s00345-024-05218-4]

Young age and adequate BCG are key factors for optimal BCG treatment efficacy in non-muscle-invasive bladder cancer

Castellani, Daniele;
2024-01-01

Abstract

Objective To investigate the impact of ageing on survival outcomes in Bacillus Calmette–Guérin (BCG) treated non-muscle invasive bladder cancer (NMIBC) patients and its synergy with adequate BCG treatment. Method Patients with NMIBC who received BCG treatment from 2001 to 2020 were divided into group 1 (<=70 years) and group 2 (>70 years). Overall Survival (OS), Cancer-Specifc Survival (CSS), Recurrence-Free Survival (RFS), and Progression-Free Survival (PFS) were analyzed using the Kaplan–Meier method. Multivariable Cox regression analysis was used to adjust potential confounding factors and to estimate Hazard Ratio (HR) and 95% Confdence Interval (CI). Subgroup analysis was performed according to adequate versus inadequate BCG treatment. Results Overall, 2602 NMIBC patients were included: 1051 (40.4%) and 1551 (59.6%) in groups 1 and 2, respectively. At median follow-up of 11.0 years, group 1 (<=70 years) was associated with better OS, CSS, and RFS, but not PFS as compared to group 2 (>70 years). At subgroup analysis, patients in group 1 treated with adequate BCG showed better OS, CSS, RFS, and PFS as compared with inadequate BCG treatment in group 2, while patients in group 2 receiving adequate BCG treatment had 41% less progression than those treated with inadequate BCG from the same group. Conclusions Being younger (<=70 years) was associated with better OS, CSS, and RFS, but not PFS. Older patients (>70 years) who received adequate BCG treatment had similar PFS as those younger with adequate BCG treatment.
2024
Non, Muscle, Invasive bladder cancer, Age, Overall survival, Cancer, Specifc survival, Recurrence, Free survival, Progression, Free survival
File in questo prodotto:
File Dimensione Formato  
Liu_Young-age-adequate-BCG-are-key-factors_2024.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza d'uso: Creative commons
Dimensione 1.45 MB
Formato Adobe PDF
1.45 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11566/335133
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 2
social impact